Why was the cohort set up?
==========================

The number of people aged 60 years or older is projected to significantly increase in the coming decades worldwide. According to United Nations estimates, this figure is expected to more than double by 2050 and to more than triple by 2100.[@dyz077-B1] Population ageing poses major challenges for the traditional social welfare state due to the greater needs for health and social care of older people.[@dyz077-B1]

This project, Ageing Trajectories of Health -- Longitudinal Opportunities and Synergies (ATHLOS), funded by the European Union's Horizon 2020 Research and Innovation Program, aims to achieve a better understanding of the impact of ageing on health by developing a new single measure of health status. With this measure, the project intends to identify patterns of healthy ageing trajectories and their determinants, the critical points in time when changes in trajectories are produced, and to propose timely clinical and public health interventions to optimize and promote healthy ageing. To achieve this, a new cohort has been composed from harmonized datasets of existing international longitudinal cohorts related to health and ageing.

The ATHLOS project follows the World Health Organization's definition of healthy ageing by studying healthy ageing as an ongoing process of developing and maintaining the functional ability that enables wellbeing in older age.[@dyz077-B2] This ongoing process interacts with the environment in which people live and can either favour health or be harmful to it. Environments are highly influential on individual behaviour, exposure to health risks, access to quality health and social care and the opportunities that ageing brings.[@dyz077-B2] Healthy ageing is thus not a unitary phenomenon but must be deconstructed into its components: mental (e.g. cognitive decline), physical (e.g. activities of daily living) and social functioning (e.g. participation in community activities).[@dyz077-B3]

National and international research funding agencies and governments have supported several follow-up studies of population cohorts since the early 1990s \[e.g. the 'Health and Retirement Study' (HRS)[@dyz077-B6]\]. HRS has been used as a model for many other longitudinal studies in a number of countries, such as the 'English Longitudinal Study of Ageing' (ELSA),[@dyz077-B7]^,^[@dyz077-B8] the 'Japanese Study of Aging and Retirement' (JSTAR),[@dyz077-B9] the 'Mexican Health and Aging Study' (MHAS),[@dyz077-B10] the 'China Health and Retirement Longitudinal Study' (CHARLS),[@dyz077-B11] the 'Longitudinal Aging Study in India' (LASI)[@dyz077-B12] or the 'Korean Longitudinal Study of Ageing' (KLOSA),[@dyz077-B13] also called the 'HRS-family' studies.[@dyz077-B14] More recently, multi-country projects have also been initiated, such as the Study on Global Ageing and adult health (SAGE) funded by the World Health Organization,[@dyz077-B15] the Survey of Health, Ageing and Retirement in Europe (SHARE) funded by the European Commission[@dyz077-B16] and the 10/66 dementia research study.[@dyz077-B17]

Although these studies have been powered to provide relevant national estimates, sample sizes might be limited for assessing the joint effect of several predisposing and protective factors.[@dyz077-B18] Additionally, although cross-country comparisons provide evidence of how contextual and health care factors impact population health, the few existing multi-country studies are limited to a selected group of countries and require a significant amount of time, co-ordination and financial resources.

Recently, strategies to harmonize data a posteriori from different longitudinal studies have been proposed to overcome some of the challenges stated above. For example, the Gateway to Global Ageing (G2AGING) is a platform funded by the National Institute on Aging, National Institutes of Health that aims to achieve data harmonization of longitudinal studies on ageing and to facilitate cross-national comparisons in population survey data.[@dyz077-B14] To date, G2AGING has harmonized the HRS datasets with the datasets of the other nine 'HRS-family' studies. In a broader context, an international research programme, called Maelstrom Research, provides systematic harmonization methodology and tools with the aim of leveraging the creation of research collaborations.[@dyz077-B18] In the context of ageing, Maelstrom Research has facilitated research consortia including the Integrative Analysis of Longitudinal Studies of Aging and Dementia (IALSA), which harmonized 9 studies, and the Promoting Mental Well-being and Healthy Ageing in Cities (MINDMAP), which incorporates 10 studies.[@dyz077-B19] These consortia have a specific focus on ageing and health and cover populations mostly from North America and Europe.

The ATHLOS consortium constitutes a new collaborative research project that, among other things, uses the Maelstrom Research resources. Unlike G2AGING, Maelstrom Research offers open-source software and guidelines to harmonize data according to concrete research aims. Thus, a harmonized dataset comprising at least 17 longitudinal population studies, from Europe and international countries, was created. These studies include information on common health conditions, as well as a detailed assessment of participants' functioning. Integrating data from existing cohort studies leads to greater sample size and statistical power to more precisely estimate the determinants and risk factors of healthy ageing. Furthermore, ageing trajectories can be compared between different countries and populations to evaluate if different cultures have diverse risk factors impacting the population's healthy ageing.

Who is in the ATHLOS cohort?
============================

The cohort comprises more than 411 000 individuals who participated in 17 general population longitudinal studies in 38 countries. The studies are the 10/66 Dementia Research Group Population-Based Cohort Study,[@dyz077-B17] the Australian Longitudinal Study of Aging (ALSA),[@dyz077-B20] the ATTICA Study,[@dyz077-B21] CHARLS,[@dyz077-B11] Collaborative Research on Ageing in Europe (COURAGE),[@dyz077-B22] ELSA,[@dyz077-B7] Study on Cardiovascular Health, Nutrition and Frailty in Older Adults in Spain (ENRICA),[@dyz077-B23] the Health, Alcohol and Psychosocial factors in Eastern Europe Study (HAPIEE),[@dyz077-B24] the Health 2000/2011 Survey,[@dyz077-B25] HRS,[@dyz077-B6] JSTAR,[@dyz077-B9] KLOSA,[@dyz077-B13] MHAS,[@dyz077-B10] SAGE,[@dyz077-B15] SHARE,[@dyz077-B16] the Irish Longitudinal Study of Ageing (TILDA)[@dyz077-B26] and the Uppsala Birth Cohort Multigenerational Study (UBCoS).[@dyz077-B27]^,^[@dyz077-B28]

Each study includes one or more populations and provides data on health determinants and age-related events. An overview of the included studies and their target populations is provided in [Table 1](#dyz077-T1){ref-type="table"}. [Table 2](#dyz077-T2){ref-type="table"} presents sample sizes and response rates at baseline for each study and population. The median percentage of response rate at each study's baseline was 75%, and the range was from 53% (SAGE-Mexico) to 96% (10/66-Rural China). It should be noted that the sample sizes of the CHARLS, ELSA, Health 2000/2011, HRS, JSTAR, MHAS and SHARE studies were increased in posterior waves of data collection. [Supplementary Table S1](#sup1){ref-type="supplementary-material"}, available as [Supplementary data](#sup1){ref-type="supplementary-material"} at *IJE* online, presents sample sizes, number of new participants, deceased participants and drop-outs for each study, population and wave.

###### 

List of studies included in the ATHLOS project

  Studies          Countries/populations[^a^](#tblfn1){ref-type="table-fn"}                         Recruitment[^d^](#tblfn4){ref-type="table-fn"}                                                               Refreshment                                                                                            
  ---------------- -------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------ --------------------
  10/66            The 10/66 Dementia Research Group Population-Based Cohort Study                  Cuba, India, China, Dominican Republic, Venezuela, Peru, Mexico and Puerto Rico                              All 65+ respondents in a household                                                                     No
  ALSA             The Australian Longitudinal Study of Aging                                       Australia: Participants drawn from the South Australian Electoral Roll                                       All 65+ respondents in a household                                                                     No
  ATTICA           The ATTICA Study                                                                 Greece: Metropolitan Athens area                                                                             18+ participants                                                                                       No
  CHARLS           The China Health and Retirement Longitudinal Study                               China: All counties except Tibet                                                                             45+ participants and spouses                                                                           Wave 2
  COURAGE          Collaborative Research on Ageing in Europe                                       Spain and Poland                                                                                             18+ participants                                                                                       No
  ELSA             The English Longitudinal Study of Ageing                                         UK and Northern Ireland                                                                                      50+ participants and spouses                                                                           Wave 3, 4, 6
  ENRICA           Study on Cardiovascular Health, Nutrition and Frailty in Older Adults in Spain   Spain                                                                                                        60+ participants                                                                                       No
  HAPIEE           The Health, Alcohol and Psychosocial factors in Eastern Europe Study             Poland, Czech Republic and Lithuania                                                                         45--69 participants                                                                                    No
  HEALTH 2000-11   The Health 2000--2011 Survey                                                     Finland                                                                                                      30+ participants                                                                                       Wave 2
  HRS              The Health and Retirement Survey                                                 United States: 6 birth sub-cohorts                                                                           50+ participants and spouses                                                                           All waves
  JSTAR            The Japanese Study of Aging and Retirement                                       Japan: 5 cities sub-cohort, 2 cities sub-cohort and 3 cities sub-cohort[^b^](#tblfn2){ref-type="table-fn"}   50--75 participants                                                                                    No
  KLOSA            The Korean Longitudinal Study of Ageing                                          South Korea                                                                                                  45+ participants and spouses                                                                           No
  MHAS             The Mexican Health and Aging Study                                               Mexico                                                                                                       50+ participants and spouses                                                                           Wave 3
  SAGE             WHO Study on Global Ageing and Adult Health                                      South Africa, Ghana, China, India, Russia and Mexico                                                         All 50+ respondents in a household (small sample 18+)                                                  No
  SHARE            The Survey of Health, Ageing and Retirement in Europe                            20 countries[^c^](#tblfn3){ref-type="table-fn"}                                                              50+ participants and spouses                                                                           All waves
  TILDA            The Irish Longitudinal Study of Ageing                                           Ireland                                                                                                      50+ participants and spouses                                                                           No
  UBCOS            The Uppsala Birth Cohort Multigenerational Study                                 Sweden: Births at the Uppsala Academic Hospital between 1915 and 1929                                        Hospital records, census records, and register data. Spouses, descendants and spouses of descendants   Descendants cohort

Although several studies were conducted in the same countries, the probability that the same individual participated in more than one study is likely very small because all study designs included a probability sample from the general population.

5 cities: Adachi-Kanazawa-Shirakawa-Sendai-Takikawa; 2 cities: Tosu-Naha; 3 cities: Chofu-Tondabayashi-Hiroshima.

Countries included in the SHARE study from waves 1 to 5: Denmark, Sweden, Austria, France, Germany, Switzerland, Belgium, the Netherlands, Spain, Italy, Greece, Israel, Czech Republic, Poland, Ireland, Estonia, Hungary, Slovenia, Portugal and Luxembourg.

Values are ages in years.

###### 

Coverage time of interview, sample sizes and response rates at baseline of each study and population included in the ATHLOS cohort

  Study /                                       Population                                     Year of interview   Sample size[^a^](#tblfn8){ref-type="table-fn"} at baseline   Response rate at baseline                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  --------------------------------------------- --------------------------------------------- ------------------- ------------------------------------------------------------ --------------------------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- -------- ------------------------------------------------------------------------------- -------- -------- -------- --------- --------- --------- -------------------------------------------- -------------------------------------------- -------------------------------------------- --------------------------------------------- --------------------------------------------- ------- ------- ----
  10/66                                         Cuba                                                                                                                                                                                                                                **W1**   ** **    ** **                                        ** **                                       **W2**   ** **    ** **     ** **     ** **                                                                              2813                                          94                                                                                                                                  
  India                                                                                                                                                                                                                                                                    ** **    **W1**   ** **    **W2**                                       ** **                                       ** **    ** **    ** **     ** **                                           2004                                          72                                                                                                                                                                               
  Urban China                                                                                                                                                                                                                                                              ** **    **W1**   ** **    ** **                                        ** **                                       ** **    **W2**   ** **     ** **     ** **     ** **                                                                                                                 1160                                          74                                                                                     
  Rural China                                                                                                                                                                                                                                                              ** **    **W1**   ** **    ** **                                        ** **                                       **W2**   ** **    ** **     ** **     ** **                                                                              1002                                          96                                                                                                                                  
  Dominican Rep.                                                                                                                                                                                                                                                           ** **    **W1**   ** **    ** **                                        ** **                                       **W2**   ** **    ** **     ** **                                           2011                                          95                                                                                                                                                                               
  Venezuela                                                                                                                                                                                                                                                                ** **    ** **    **W1**   ** **                                        ** **                                       **W2**   ** **    ** **     ** **                                           1965                                          80                                                                                                                                                                               
  Urban Peru                                                                                                                                                                                                                                                               ** **    ** **    **W1**   ** **                                        ** **                                       **W2**   ** **    ** **     ** **                                           1381                                          80                                                                                                                                                                               
  Rural Peru                                                                                                                                                                                                                                                               ** **    ** **    **W1**   ** **                                        ** **                                       **W2**   ** **    ** **     ** **     ** **                                                                              552                                           88                                                                                                                                  
  Urban Mexico                                                                                                                                                                                                                                                             ** **    ** **    **W1**   ** **                                       **W2**                                       ** **    ** **    ** **                         1003                         84                                                                                                                                                                                                                            
  Rural Mexico                                                                                                                                                                                                                                                             ** **    ** **    ** **    **W1**                                       ** **                                       **W2**   ** **    ** **     ** **                                           1000                                          86                                                                                                                                                                               
  Puerto Rico                                                                                                                                                                                                                                                              ** **    ** **    ** **    ** **                                       **W1**                                       ** **    ** **    **W2**                        2009                         93                                                                                                                                                                                                                            
  ALSA                                                                                                                                                                                                      **W1**   **W2**   **W3**   **W4**   ** **    **W5**   ** **    ** **    **W6**   ** **    ** **                                       **W7**                                       ** **    **W8**   **W9**   **W10**   **W11**    ** **                      ** **                                       **W12**                                      **W13**                                                                                      2087                        55            
  ATTICA                                                                                                                                                                                                                                                                                     **W1**   ** **                                        ** **                                       ** **    **W2**   ** **     ** **     ** **     ** **                      **W3**                                                                                                                                                                                3037                         75           
  CHARLS                                                                                                                                                                                                                                                                                                                                                                                                                                                                  **W1**                                       **W2**                     [^c^](#tblfn7){ref-type="table-fn"} **W3**   [^c^](#tblfn7){ref-type="table-fn"} **W4**                       18245                       81            
  COURAGE                                       Spain                                                                                                                                                                                                                                                                                                                                                                                                                                                                  **W1**                                       ** **                                        **W2**                                         4753                        70            
  Poland                                                                                                                                                                                                                                                                                                                                                                                                                                                                  **W1**                                       ** **                                        ** **                                        **W2**                                         4071                        67            
  ELSA                                                                                                                                                                                                                                                                                       **W1**   ** **                                       **W2**                                       ** **    **W3**   ** **    **W4**     ** **    **W5**                      ** **                                        **W6**                                                                                    **W7**                                         12099                       66            
  ENRICA                                                                                                                                                                                                                                                                                                                                                                                                                  **W1**     ** **    **W2**                      ** **                                        ** **                                        **W3**                                        2519                                           60                                       
  HAPIEE                                        Poland                                                                                                                                                                                                                                                **W1**                                      **W2**                                                                                                                                                               10728                                          61                                                                                                                                  
                                                                                                                                                                                                                                                                                    ** **    ** **    ** **    **Mortality and Cardiovascular followup** [^b^](#tblfn6){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                              
  Czech Republic                                                                                                                                                                                                                                                                             **W1**   ** **                                       **W2**                                                                                                                                                                                                             8857                                          55                                                                                     
                                                                                                                                                                                                                                                                                    ** **    ** **    ** **    **Mortality and Cardiovascular followup** [^b^](#tblfn6){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                              
  Lithuania                                                                                                                                                                                                                                                                                  ** **    ** **                                        ** **                                       **W1**                                                                                                                                                                7111                                          65                                                                                     
                                                                                                                                                                                                                                                                                    ** **    ** **    ** **    **Mortality and Cardiovascular followup** [^b^](#tblfn6){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                              
  HEALTH 2000/2011                                                                                                                                                                        ** **             ** **    ** **    ** **    ** **    ** **    ** **    ** **    **W1**                                                                                                                                                             **W2**                                                                   ** **                                                                                      8028                                           93                                       
  HRS                                           HRS sub-sample                                                                                                                                              **W1**   ** **    **W2**   ** **    **W3**   ** **    **W4**   ** **    **W5**   ** **    **W6**                                       ** **                                       **W7**   ** **    **W8**    ** **    **W9**     ** **                     **W10**                                                                                   **W11**                                        ** **                      [^c^](#tblfn7){ref-type="table-fn"} **W12**           12787   82
  AHEAD                                                                                                                                                                                   ** **             **W2**   ** **    **W3**   ** **    ** **    **W4**   ** **    **W5**   ** **    **W6**   ** **                                       **W7**                                       ** **    **W8**   ** **    **W9**     ** **    **W10**                                                                 **W11**                                       ** **                      [^c^](#tblfn7){ref-type="table-fn"} **W12**                                                 8297     80    
  CODA                                                                                                                                                                                    ** **             ** **    ** **    ** **    ** **    ** **    **W4**   ** **    **W5**   ** **    **W6**   ** **                                       **W7**                                       ** **    **W8**   ** **    **W9**     ** **    **W10**                                                                 **W11**                                       ** **                      [^c^](#tblfn7){ref-type="table-fn"} **W12**                                                 2364     73    
  WBB                                                                                                                                                                                     ** **             ** **    ** **    ** **    ** **    ** **    **W4**   ** **    **W5**   ** **    **W6**   ** **                                       **W7**                                       ** **    **W8**   ** **    **W9**     ** **    **W10**                                                                 **W11**                                       ** **                      [^c^](#tblfn7){ref-type="table-fn"} **W12**                                                 2622     70    
  EBB                                                                                                                                                                                     ** **             ** **    ** **    ** **    ** **    ** **    ** **    ** **    ** **    ** **    ** **    ** **                                       **W7**                                       ** **    **W8**   ** **    **W9**     ** **    **W10**                                                                 **W11**                                       ** **                      [^c^](#tblfn7){ref-type="table-fn"} **W12**                                                 3400     75    
  MBB                                                                                                                                                                                     ** **             ** **    ** **    ** **    ** **    ** **    ** **    ** **    ** **    ** **    ** **    ** **                                        ** **                                       ** **    ** **    ** **     ** **     ** **    **W10**                                                                 **W11**                                       ** **                      [^c^](#tblfn7){ref-type="table-fn"} **W12**                                                 5102           
  JSTAR                                         5 cities[^d^](#tblfn8){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                               **W1**     ** **    **W2**                      ** **                                        **W3**                                                                                                                                                                      3862    60
  2 cities[^e^](#tblfn6){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                                    ** **     ** **    **W1**     ** **                      **W2**                                                                                                                                                                                                           1440           
  3 cities[^f^](#tblfn7){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                                    ** **     ** **     ** **     ** **                      **W1**                                                                                                                                                                                                           1966           
  KLOSA                                                                                                                                                                                                                                                                                                                                                                                                 **W1**            **W2**              **W3**                                                                   **W4**                                                                  [^c^](#tblfn7){ref-type="table-fn"} **W5**                                                  10254    64    
  MHAS                                                                                                                                                                                                                                                                              **W1**   ** **    **W2**                                       ** **                                       ** **    ** **    ** **     ** **     ** **     ** **                      ** **                                        **W3**                                                                  [^c^](#tblfn7){ref-type="table-fn"} **W4**                                                  15146    89    
  SAGE                                          South Africa                                                                                                                                                                                                                                                                                                                                                              **W1**     ** **     ** **                                                                                                                                           [^c^](#tblfn7){ref-type="table-fn"} **W2**                       4227                        75            
  Ghana                                                                                                                                                                                                                                                                                                                                                                                                          **W1**    ** **     ** **                                                                                                        [^c^](#tblfn7){ref-type="table-fn"} **W2**                      5573                                           81                                       
  China                                                                                                                                                                                                                                                                                                                                                                                                          **W1**                                 [^c^](#tblfn7){ref-type="table-fn"} **W2**                     15050                                          93                                                                                                                                  
  India                                                                                                                                                                                                                                                                                                                                                                                                          **W1**    ** **     ** **     ** **                                                                                                                                           [^c^](#tblfn7){ref-type="table-fn"} **W2**                       12198                       68            
  Russia                                                                                                                                                                                                                                                                                                                                                                                                         **W1**                                 [^c^](#tblfn7){ref-type="table-fn"} **W2**                      4947                                          83                                                                                                                                  
  Mexico                                                                                                                                                                                                                                                                                                                                                                                                         ** **     ** **    **W1**                                                                                                        [^c^](#tblfn7){ref-type="table-fn"} **W2**                      5448                                           53                                       
  SHARE                                                                                                                                                                                                                                                                                                                                           **W1**                                       ** **    **W2**   ** **    **W3**     ** **    **W4**                      ** **                                        ** **                                        **W5**                                        ** **                      [^c^](#tblfn7){ref-type="table-fn"} **W6**    30816    62    
  TILDA                                                                                                                                                                                                                                                                                                                                                                                                                                       **W1**                      **W2**                     [^c^](#tblfn7){ref-type="table-fn"} **W3**                      8504                                          62                                                                                     
  UBCOS                                         Birth generation                                  **W1 - W4**                                **W5**                                      **W6**                                                                            20732      \-                                                                                                                                                                                                                                                                                                                                                                                                                  
  Descendants                                   ** **                                             **W1 - W4**                                **W5**                                      **W6**                                                                            33052                                                                                                                                                                                                                                                                                                                                                                                                                          

Sample sizes derived from datasets provided by the study owners. Spouses of participants can be included.

The HAPIEE study has a continuous mortality and cardiovascular follow-up from 2005 to 2015.

Dataset will eventually be included.

5 cities: Adachi-Kanazawa-Shirakawa-Sendai-Takikawa.

2 cities: Tosu-Naha.

3 cities: Chofu-Tondabayashi-Hiroshima.

All studies are cohorts based on questionnaires except for the UBCoS study, which collects routine health and social data for all babies born in the Uppsala Academic Hospital between the years 1915 and 1929, and their descendants. The UBCoS data were converted into periods of data collection to resemble the design of the other studies.

Finally, the study on the Identification of health and disability determinants on ageing in Italy (IDAGIT) will be subsequently included in the cohort.

How often have participants been followed up?
=============================================

Most of the longitudinal studies included in the ATHLOS harmonized dataset started between 2000 and 2010 and have at least 2 waves of data collection (see [Table 2](#dyz077-T2){ref-type="table"}). ALSA and HRS started much earlier, in the 1990s, and have more than 10 waves of data collection. SAGE has only 1 wave of data harmonized to date. However, new waves of data are expected to be harmonized in the future.

Regarding UBCoS, as register data have been collected approximately every 10 years from 1960 to 2008, we distributed the data in 6 waves.

What has been harmonized?
=========================

The data harmonization requires an a priori definition of the variables of interest and their possible values. Thus, the ATHLOS consortium defined a wide range of variables, called DataSchema variables, which included all health conditions, sociodemographic variables, personal functioning and contextual factors. These are usually assessed in population studies. Variables that have international standards or have been created by well-known scales and measured tests were employed in the harmonization process. For example, the International Classification of Functioning, Disability and Health (ICF) biopsychosocial model[@dyz077-B29] and the conceptualization of health suggested by the World Health Organization[@dyz077-B30] were used for characterizing the functioning-related variables.

The DataSchema variables were classified as follows: (i) sociodemographic and economic characteristics; (ii) lifestyle and health behaviours; (iii) health status and functional limitations; (iv) diseases; (v) death; (vi) physical measures; (vii) psychological measures; (viii) laboratory measures; (ix) social environment and life events; and (x) other administrative information. In [Table 3](#dyz077-T3){ref-type="table"}, a list of core variables within the aforementioned domains, together with the individual studies, is provided.

###### 

List of the core variables for the harmonized ATHLOS datasets and the studies including potential information to be harmonized in at least one population or wave

  Domain                                          Sub-domains                                         10/66   ALSA    ATTICA   CHARLS   COURAGE    ELSA    ENRICA  HAPIEE   H2000/11   HRS     JSTAR   KLOSA   MHAS    SAGE    SHARE   TILDA   UBCoS
  ----------------------------------------------- --------------------------------------------------- ------- ------- -------- -------- --------- ------- -------- -------- ---------- ------- ------- ------- ------- ------- ------- ------- -------
  Sociodemographic and economic characteristics   Birth                                               **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**
  Sex                                             **✓**                                               **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   
  Marital status                                  **✓**                                               **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   
  Education                                       **✓**                                               **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   
  Living alone                                    **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **×**   **✓**    **✓**      **×**   **✓**   **×**   **✓**   **✓**   **✓**   **✓**   
  Employment/retirement                           **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   
  Wealth                                          **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **×**   **×**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   
  Lifestyle and health behaviours                 Tobacco                                             **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**
  Alcohol                                         **✓**                                               **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   
  Physical activity                               **✓**                                               **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **×**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   
  Health status and functional limitations        Memory                                              **✓**   **×**   **×**    **✓**    **✓**      **✓**   **×**   **×**    **✓**      **✓**   **×**   **×**   **✓**   **✓**   **✓**   **✓**   **×**
  Dizziness                                       **×**                                               **✓**   **×**   **×**    **×**    **✓**      **×**   **×**   **×**    **✓**      **×**   **×**   **×**   **×**   **✓**   **×**   **×**   
  Orientation                                     **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **×**   **×**    **✓**      **✓**   **×**   **×**   **×**   **✓**   **✓**   **×**   
  Walking speed                                   **×**                                               **×**   **×**   **✓**    **✓**    **✓**      **✓**   **×**   **✓**    **✓**      **×**   **×**   **✓**   **✓**   **✓**   **✓**   **×**   
  Energy                                          **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**   
  Sleep                                           **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**   
  Pain                                            **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **×**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**   
  Incontinence                                    **✓**                                               **✓**   **×**   **✓**    **×**    **✓**      **✓**   **×**   **✓**    **✓**      **×**   **✓**   **✓**   **×**   **✓**   **✓**   **×**   
  Hearing/sight                                   **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **×**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**   
  Mobility                                        **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**   
  Activities of Daily Living (ADL)                **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**   
  Instrumental ADL                                **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **×**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**   
  Cognitive impairment                            **✓**                                               **×**   **×**   **✓**    **✓**    **✓**      **✓**   **✓**   **×**    **✓**      **✓**   **×**   **✓**   **✓**   **✓**   **✓**   **×**   
  Self-reported health                            **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**   
  Falls                                           **✓**                                               **✓**   **×**   **✓**    **×**    **✓**      **✓**   **×**   **✓**    **✓**      **×**   **✓**   **✓**   **×**   **✓**   **✓**   **×**   
  Diseases                                        Diabetes                                            **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**
  Respiratory                                     **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   
  Hypertension                                    **✓**                                               **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   
  Joint disorders                                 **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **×**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   
  Cardiovascular disease                          **✓**                                               **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   
  Cancer                                          **×**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **×**   **✓**   **✓**   **✓**   
  Death                                           Living status                                       **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **×**   **✓**   **×**   **✓**
  Physical measures                               Body measures                                       **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**
  Grip strength                                   **×**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **×**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   
  Blood pressure                                  **✓**                                               **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**   
  Psychological measures                          Screening measure of cognition                      **×**   **✓**   **×**    **×**    **✓**      **×**   **✓**   **×**    **✓**      **×**   **×**   **✓**   **×**   **×**   **×**   **✓**   **×**
  Depression                                      **✓**                                               **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**   
  Anxiety                                         **✓**                                               **×**   **✓**   **×**    **✓**    **✓**      **✓**   **×**   **✓**    **×**      **×**   **×**   **×**   **✓**   **×**   **✓**   **×**   
  Laboratory measures                             Glucose, cholesterol, ...                           **×**   **×**   **✓**    **×**    **×**      **✓**   **✓**   **✓**    **✓**      **×**   **×**   **×**   **✓**   **×**   **×**   **✓**   **×**
  Social environment and life events              Social network                                      **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**
  Social support                                  **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **×**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**   
  Social participation                            **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **×**   **✓**   **✓**    **×**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**   
  Social trust/cohesion                           **×**                                               **×**   **×**   **×**    **✓**    **✓**      **×**   **✓**   **✓**    **×**      **✓**   **×**   **×**   **✓**   **✓**   **×**   **×**   
  Life events                                     **✓**                                               **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**   
  Loneliness                                      **✓**                                               **✓**   **×**   **✓**    **✓**    **✓**      **×**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **×**   
  Administrative variables                        ID participant/household, date of interview, etc.   **✓**   **✓**   **✓**    **✓**    **✓**      **✓**   **✓**   **✓**    **✓**      **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**   **✓**

What has ATHLOS found? Key findings and publications
====================================================

ATHLOS includes data from all populated continents, with Europe being the most represented. Sociodemographic information by continent and country is shown in [Table 4](#dyz077-T4){ref-type="table"}. The median year of birth was around the 1940s, with people from America being older (born in the 1930s) and those in Australia much older (born in 1914). Overall, the median age at baseline was about 60 years. Sweden exhibits a younger average age at baseline, as UBCoS cohorts were based on register data starting in 1960. The percentage of female participants was slightly above 50%, other than in Australia and Ghana, which had lower percentages. The average percentage of primary education or less stood at about 37%, but in general there was heterogeneity even in countries from the same study as in SHARE. In Europe, for example, the lowest percentage was observed in Germany (2%) and the highest percentage in Spain (58%); in South America, the percentage was very high in Venezuela (81%) and Dominican Republic (90%).

###### 

Descriptive statistics of some sociodemographic variables by continent and country

  Continent            Country                    *n*     Year of birth (median)   Age at participant\'s baseline (median)   Female (%)    Primary education or less (%)  Studies involved
  -------------------- -------------------------- ------- ------------------------ ----------------------------------------- ------------ ------------------------------- ---------------------
  Europe               Austria                    6411    1945                     63                                        58                         14                SHARE
  Belgium              8720                       1948    60                       55                                        21                        SHARE              
  Czech Republic       18092                      1946    60                       56                                        14                    HAPIEE, SHARE          
  Denmark              5553                       1948    60                       54                                        13                        SHARE              
  Estonia              7075                       1945    65                       59                                        6                         SHARE              
  Finland              9673                       1948    47                       54                                        47                     Health2000            
  France               8105                       1946    61                       57                                        40                        SHARE              
  Germany              8690                       1946    62                       54                                        2                         SHARE              
  Greece               6969                       1949    55                       54                                        38                    ATTICA, SHARE          
  Hungary              3076                       1948    63                       57                                        2                         SHARE              
  Ireland              9638                       1948    62                       46                                        29                    SHARE, TILDA           
  Italy                7158                       1945    63                       55                                        48                        SHARE              
  Lithuania            7111                       1945    61                       55                                        12                    HAPIEE, SHARE          
  Luxembourg           1610                       1950    62                       53                                        37                        SHARE              
  Netherlands          6547                       1946    61                       54                                        14                        SHARE              
  Poland               17532                      1947    58                       54                                        20               COURAGE, HAPIEE, SHARE      
  Portugal             2080                       1947    64                       57                                        56                        SHARE              
  Slovenia             3755                       1948    63                       56                                        10                        SHARE              
  Spain                15952                      1944    65                       54                                        58               COURAGE, ENRICA, SHARE      
  Sweden               66243                      1945    16                       50                                        35                    SHARE, UBCoS           
  Switzerland          4571                       1946    62                       55                                        11                        SHARE              
  United Kingdom       18489                      1944    59                       54                                        38                        ELSA               
  Eurasia              Russia                     4947    1946                     62                                        64                          9                SAGE
  Asia                 China                      38990   1951                     59                                        53                         60                10/66, CHARLS, SAGE
  India                14202                      1947    55                       61                                        58                     10/66, SAGE           
  Israel               3857                       1946    61                       55                                        21                        SHARE              
  Japan                7268                       1945    63                       52                                        25                        JSTAR              
  South Korea          10254                      1945    61                       56                                        45                        KLOSA              
  North America        United States of America   37317   1938                     56                                        56                         27                HRS
                       Cuba                       2813    1930                     74                                        65                         58                10/66
  Dominican Republic   2011                       1931    74                       66                                        90                        10/66              
  Mexico               28817                      1944    59                       58                                        72                  10/66, MHAS, SAGE        
  Puerto Rico          2009                       1932    76                       67                                        44                        10/66              
  South America        Peru                       1933    1932                     74                                        61                         56                10/66
                       Venezuela                  1965    1935                     71                                        64                         81                10/66
  Africa               Ghana                      5573    1950                     60                                        49                         47                SAGE
  South Africa         4227                       1947    60                       57                                        62                        SAGE               
  Oceania              Australia                  2087    1914                     78                                        49                         36                ALSA
  Total                411320                     1945    58                       54                                        37                   The 17 studies          

Advanced analytical approaches have already been applied to some studies of the ATHLOS dataset to test the methodology for developing a single measure of health status and to identify different patterns of health trajectories over time. This measure will allow for the comparison of health status across populations and longitudinal studies included in ATHLOS. Specifically, these analyses have already been conducted on harmonized datasets comprising ELSA and HRS studies. Evidence suggests that the average health scores and trajectories are sensitive to age and that the health status measure is a good predictor of mortality.[@dyz077-B31]^,^[@dyz077-B32]

Additionally, a large systematic review (with more than 90 000 articles screened) was conducted to summarize and synthesize the current evidence on social, biological, behavioural, psychological and sociodemographic determinants of healthy ageing.[@dyz077-B33] This systematic review indicated limited research about healthy ageing in low- and middle-income countries and confirmed the heterogeneity in the conceptualization and definition of healthy ageing.

What are the main strengths and weaknesses of ATHLOS?
=====================================================

The harmonized dataset in the ATHLOS project constitutes a new cohort that has been created by collecting data from 17 longitudinal studies from five continents. The harmonization approach and tools used in this project were adapted from the methodology developed by Maelstrom Research.[@dyz077-B18] This approach is systematic and rigorous to ensure that harmonized variables are comparable.

It should be noted that the harmonization is a retrospective process, as studies were not initially designed to be harmonized. The heterogeneity in study design, instruments and data collection limits the amount and quality of information that can be pooled.[@dyz077-B34] Thus, we are conducting thorough documentation of the whole process, not only for the sake of reproducibility and transparency, but also to estimate the quality of harmonization for every variable.

What are the main problems inherent to the harmonization?
=========================================================

In the course of the harmonization process, we encountered several challenges. First, the harmonization potential is a trade-off between the number of studies (quantity) that can be included and the content equivalence (precision) within the study-specific variables. For example, education can be harmonized using standard criteria, such as the ISCED2011,[@dyz077-B35] creating a categorical variable based on the highest qualification or generating a continuous variable for years of education. Greater precision in the definition of education would entail a lower number of studies that could be included. Second, some variables were at times conceptually different across studies, even though they described the same underlying construct. For example, employment may be addressed directly (e.g. are you employed?) or indirectly (e.g*.* are you retired?). The same applies to energy level, which can be addressed in terms of presence of energy (e.g. do you have energy for daily life?) or inversely (e.g. did you feel tired out or low in energy?). In this case, our intention was to address the variable in aggregate and not the way in which the question was asked. Further, ethical and legal issues may restrict the sharing and pooling of individual data. For example, studies may not publicly provide biomarker or mortality information of participants who have been lost to follow-up. Therefore, managing and pooling large datasets from different studies poses significant challenges, but the advantages seem worthwhile if we consider the global coverage and the gain in statistical power.[@dyz077-B36]

Can I get hold of the data? Where can I find out more?
======================================================

A platform of free software applications, developed by Maelstrom Research, is used to store the original datasets, guide the harmonization process and create a web portal for the studies from the ATHLOS Consortium, as well as the final harmonized databases.[@dyz077-B37] These software applications have General Public Licences and can therefore be used and freely modified according to the ATHLOS project needs. The web catalogue can be found at: <https://athlos.pssjd.org>. Full access to statistical summaries and reports of the harmonization process for each variable in each study requires registration. Documentation of the whole harmonization process for each variable in each study is publicly shared at: <https://github.com/athlosproject/athlos-project.github.io/>

No individual dataset can be downloaded from these websites. Harmonized datasets with individual data are stored on a secure server. At this stage of the project, only researchers and collaborators of the ATHLOS Consortium can download harmonized datasets, unless study owners provide their consent. Thus, external users should contact the Scientific Committee (<athlos@pssjd.org>), comprised of members of the ATHLOS Consortium, to access the harmonized datasets. Alternatively, users could access original datasets directly from the study owners and follow the documentation and codes published in the abovementioned \`github\` webpage.

Profile in a nutshellThe Ageing Trajectories of Health -- Longitudinal Opportunities and Synergies (ATHLOS) cohort harmonizes existing longitudinal data from 17 international cohort studies.It aims to achieve a better understanding of the impact of ageing on health and to propose timely clinical and public health interventions to optimize and promote healthy ageing.The cohort comprises more than 411 000 individuals from 38 countries. Most of the studies started between 2000 and 2010 and have between 2 and 13 waves of data collection. New waves of data collected during the ATHLOS project and other studies will be incorporated in updated versions of the harmonized dataset.Harmonized datasets include variables classified in the following areas: (i) sociodemographic and economic characteristics; (ii) lifestyle and health behaviours; (iii) health status and functional limitations; (iv) diseases; (v) death; (vi) physical measures; (vii) psychological measures; (viii) laboratory measures; (ix) social environment and life events; and (x) other administrative information.The catalogues of the studies and final harmonized databases, together with documentation of the whole harmonization process, can be found in the web portal: (<https://athlos.pssjd.org>). External users interested in using the harmonized datasets should contact the ATHLOS Scientific Committee: (<athlos@pssjd.org>).
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